// App-Quantinova.ai

SAT0364 : Pentraxin 3 as Biomarker in Assessment of Disease Activity in Takayasu Arteritis

Researchers

Presenter

  • P.K. Devarasetti

Principal Investigators

  • S.K. Appani

  • R.V.P. Irlapati

  • L. Rajasekhar

Medical Centers

  • Department of Rheumatology, Nizam Institute of Medical Sciences, Hyderabad, India

Locations

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Takayasu arteritis

Biomarkers

  • C reactive protein

  • Pentraxin-3

  • High sensitivity C-reactive protein

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim